Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention
暂无分享,去创建一个
P. Carroll | V. Weinberg | K. Shinohara | M. J. Magbanua | D. Ornish | C. Haqq | M. Mattie | Vivian Weinberg | G. Weidner | Peter R. Carroll | Katsuto Shinohara | Dean Ornish | Gerdi Weidner | Ruth Marlin | J. Simko | Jeff Simko | Colleen Kemp | Colleen Kemp | Ruth O Marlin | Mark Jesus M. Magbanua | Christopher Green | Michael D. Mattie | Christopher M. Haqq | C. Green | Michael D. Mattie
[1] R. Elashoff,et al. Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy , 2008, European Journal of Clinical Nutrition.
[2] Eivind Hovig,et al. MArray: analysing single, replicated or reversed microarray experiments , 2002, Bioinform..
[3] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[4] P. Walsh,et al. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. , 2002, The Journal of urology.
[5] Yudong D. He,et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.
[6] Y. Nikolsky,et al. Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine. , 2007, Pharmacogenomics.
[7] M. Campbell,et al. PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.
[8] J. Meyerhardt,et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] E. Brown,et al. Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.
[10] B. Ljung,et al. The gene expression signatures of melanoma progression , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] Barbara Gandek,et al. Sf-12v2 How to score version 2 of the sf-12 health survey. Quality Metric Incorporated , 2002 .
[12] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[13] Peter H Gann,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.
[14] A W Partin,et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.
[15] N. Mendell,et al. Intensive lifestyle changes may affect the progression of prostate cancer. , 2005, The Journal of urology.
[16] Robert M Elashoff,et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.
[17] David Botstein,et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data , 2003, Nucleic Acids Res..
[18] J. Epstein,et al. The Utility of Basal Cell—Specific Anti‐Cytokeratin Antibody (34βE12) in the Diagnosis of Prostate Cancer: A Review of 228 Cases , 1995, The American journal of surgical pathology.
[19] Christine Chi,et al. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. , 2006, Urology.
[20] E. Giovannucci,et al. Role of diet in prostate cancer development and progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] A. Lechtermann,et al. Exercise affects the gene expression profiles of human white blood cells. , 2007, Journal of applied physiology.
[22] P. Clarke,et al. Cell Biology: Ran, Mitosis and the Cancer Connection , 2006, Current Biology.
[23] T. Uchida,et al. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in japan , 1997, Cancer.
[24] L. Niskanen,et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. , 2007, The American journal of clinical nutrition.
[25] Xin Yu,et al. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. , 2002, The American journal of pathology.
[26] E. Wynder,et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. , 1991, International journal of epidemiology.
[27] M. Horowitz,et al. Impact of Event Scale: A Measure of Subjective Stress , 1979, Psychosomatic medicine.
[28] G. W. Hatfield,et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. , 2004, Journal of applied physiology.
[29] K. Gould,et al. Intensive lifestyle changes for reversal of coronary heart disease. , 1998, JAMA.
[30] B. Tombal,et al. Free to total prostate‐specific antigen (PSA) ratio is superior to total‐PSA in differentiating benign prostate hypertrophy from prostate cancer , 1996, The Prostate. Supplement.
[31] Matthew R Cooperberg,et al. Contemporary trends in low risk prostate cancer: risk assessment and treatment. , 2007, The Journal of urology.
[32] M. Nosrati,et al. Osteopontin as a molecular prognostic marker for melanoma , 2008, Cancer.
[33] M. Mason,et al. The prevalence and predictors of psychological distress in patients with early localized prostate cancer , 2002, BJU international.
[34] L. Klotz. Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention , 2008, Nature Clinical Practice Urology.
[35] B. Tombal,et al. Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA. , 1996, Urology.
[36] Pablo Rodriguez-Viciana,et al. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. , 2006, Molecular cell.
[37] E. Rimm,et al. Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States) , 2006, Cancer Causes & Control.
[38] Stacey A. Kenfield,et al. Diet and Lifestyle Interventions in Active Surveillance Patients with Favorable-Risk Prostate Cancer , 2007, Current treatment options in oncology.
[39] F. Baehner,et al. Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] T. Downs,et al. Potential Attenuation of Disease Progression in Recurrent Prostate Cancer With Plant-Based Diet and Stress Reduction , 2006, Integrative cancer therapies.
[41] P. Carroll,et al. Dietary trial in prostate cancer: Early experience and implications for clinical trial design. , 2001, Urology.
[42] P. Arner,et al. Changes in Adipose Tissue Gene Expression with Energy-restricted Diets in Obese Women , 2022 .
[43] Ming Zhang,et al. Sno/scaRNAbase: a curated database for small nucleolar RNAs and cajal body-specific RNAs , 2006, Nucleic Acids Res..
[44] Terrence S. Furey,et al. The UCSC Genome Browser Database , 2003, Nucleic Acids Res..
[45] Kay Nieselt,et al. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise. , 2005, Physiological genomics.
[46] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.